Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:46 UTC |
---|
HMDB ID | HMDB0014856 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Adefovir Dipivoxil |
---|
Description | Adefovir Dipivoxil is only found in individuals that have used or taken this drug.Adefovir dipivoxil, previously called bis-POM PMEA, with trade names Preveon and Hepsera, is an orally-administered nucleotide analog reverse transcriptase inhibitor (ntRTI) used for treatment of hepatitis B. It is a failed treatment for HIV. [Wikipedia ]Adefovir dipivoxil is a prodrug of adefovir. Adefovir is an acyclic nucleotide analog of adenosine monophosphate which is phosphorylated to the active metabolite adefovir diphosphate by cellular kinases. Adefovir diphosphate inhibits HBV DNA polymerase (reverse transcriptase) by competing with the natural substrate deoxyadenosine triphosphate and by causing DNA chain termination after its incorporation into viral DNA. The inhibition constant (Ki) for adefovir diphosphate for HBV DNA polymerase was 0.1 μM. Adefovir diphosphate is a weak inhibitor of human DNA polymerases alpha and gamma with Ki values of 1.18 μM and 0.97μM, respectively. |
---|
Structure | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23) |
---|
Synonyms | Value | Source |
---|
Adefovir pivoxil | Kegg | Hepsera | Kegg | Adefovir | HMDB | Adefovirdipivoxl | HMDB | ADV | HMDB | Bis-pom pmea | HMDB | GS-840 | HMDB | PMEA | HMDB | Adefovir depivoxil | HMDB | 9-(2-((-Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine | HMDB | Preveon | HMDB |
|
---|
Chemical Formula | C20H32N5O8P |
---|
Average Molecular Weight | 501.4705 |
---|
Monoisotopic Molecular Weight | 501.198849537 |
---|
IUPAC Name | [({[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}({[(2,2-dimethylpropanoyl)oxy]methoxy})phosphoryl)oxy]methyl 2,2-dimethylpropanoate |
---|
Traditional Name | adefovir dipivoxil |
---|
CAS Registry Number | 142340-99-6 |
---|
SMILES | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C |
---|
InChI Identifier | InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23) |
---|
InChI Key | WOZSCQDILHKSGG-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 6-aminopurines. These are purines that carry an amino group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Imidazopyrimidines |
---|
Sub Class | Purines and purine derivatives |
---|
Direct Parent | 6-aminopurines |
---|
Alternative Parents | |
---|
Substituents | - 6-aminopurine
- Aminopyrimidine
- Dialkyl alkylphosphonate
- Phosphonic acid diester
- Dicarboxylic acid or derivatives
- Imidolactam
- Pyrimidine
- Phosphonic acid ester
- N-substituted imidazole
- Azole
- Heteroaromatic compound
- Imidazole
- Organophosphonic acid derivative
- Amino acid or derivatives
- Carboxylic acid ester
- Carboxylic acid derivative
- Azacycle
- Organophosphorus compound
- Primary amine
- Amine
- Hydrocarbon derivative
- Organic nitrogen compound
- Carbonyl group
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.63 g/L | Not Available | LogP | 0.8 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Adefovir Dipivoxil,1TMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N[Si](C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3311.3 | Semi standard non polar | 33892256 | Adefovir Dipivoxil,1TMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N[Si](C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3239.4 | Standard non polar | 33892256 | Adefovir Dipivoxil,1TMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N[Si](C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 5496.1 | Standard polar | 33892256 | Adefovir Dipivoxil,2TMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3275.4 | Semi standard non polar | 33892256 | Adefovir Dipivoxil,2TMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3301.7 | Standard non polar | 33892256 | Adefovir Dipivoxil,2TMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 4718.8 | Standard polar | 33892256 | Adefovir Dipivoxil,1TBDMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N[Si](C)(C)C(C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3457.5 | Semi standard non polar | 33892256 | Adefovir Dipivoxil,1TBDMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N[Si](C)(C)C(C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3411.3 | Standard non polar | 33892256 | Adefovir Dipivoxil,1TBDMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N[Si](C)(C)C(C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 5392.0 | Standard polar | 33892256 | Adefovir Dipivoxil,2TBDMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3610.2 | Semi standard non polar | 33892256 | Adefovir Dipivoxil,2TBDMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 3625.3 | Standard non polar | 33892256 | Adefovir Dipivoxil,2TBDMS,isomer #1 | CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=CN=C21)OCOC(=O)C(C)(C)C | 4661.5 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Adefovir Dipivoxil GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4j-9715200000-be4793aa3b5324f2d049 | 2017-09-01 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Adefovir Dipivoxil LC-ESI-qTof , Positive-QTOF | splash10-00b9-0291650000-bfacc10ec3119e8320f0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adefovir Dipivoxil , positive-QTOF | splash10-0kfx-1372940000-7cb1aa4d35fd2d90d7b4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adefovir Dipivoxil , positive-QTOF | splash10-00b9-0291650000-bfacc10ec3119e8320f0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 10V, Positive-QTOF | splash10-0udi-1902120000-70d9218f4799e4b06e06 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 20V, Positive-QTOF | splash10-0r09-4902210000-8477053656f9d74eeb50 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 40V, Positive-QTOF | splash10-0a4r-6910000000-ff29d5990721f46c8df5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 10V, Negative-QTOF | splash10-0f6t-0309020000-13dd87f577f6eae4df2c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 20V, Negative-QTOF | splash10-0udi-0903000000-3c822353c37c29284a8f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 40V, Negative-QTOF | splash10-001i-1922000000-607d6864a8d2801ab89f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 10V, Positive-QTOF | splash10-0udr-5239180000-444adb50df8e9dcc8e3c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 20V, Positive-QTOF | splash10-0fk9-0096000000-592e65840a6c7d4fec2b | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 40V, Positive-QTOF | splash10-000i-4972000000-f60e4d26bcfe1943e60c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 10V, Negative-QTOF | splash10-0udi-0429260000-3e0596d28028aed80ce0 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 20V, Negative-QTOF | splash10-0udi-1389000000-87f1f9b00d5ac0c19e44 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Adefovir Dipivoxil 40V, Negative-QTOF | splash10-00di-0090000000-6582070f7152c5e52322 | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|